Is Veda Group Ltd worth more than $2.70?

Will Veda Group Ltd (ASX:VED) reject Equifax's recent takeover offer?

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Veda Group Ltd (ASX: VED) recently received a $2.3 billion takeover offer, but it seems that mightn't be enough to get the data analytics group to agree to a deal.

On Friday, September 18, investors learned that Veda Group had received an offer from Equifax, which said it would pay $2.70 per share to acquire 100% of the company.

That represented a 35% premium to Veda's previous closing price of just $1.995. While that might seem generous at first glance, investors need to consider that the shares had fallen from $2.48 roughly six weeks earlier, despite the absence of any bad news.

The company had reported double-digit earnings growth for the 2015 financial year (FY15) and forecast double digit growth for FY16 as well highlighting the high-quality business that is Veda Group.

Another factor that needs to be considered is the introduction of the comprehensive credit reporting regime, or CCR, early last year, which could provide a huge growth avenue for Veda Group. CCR changed the way credit information can be shared by lenders for the purpose of assessing credit, thus enhancing the information companies can access when deciding whether to lend to an individual or business.

In other words, it provides a comprehensive view into a customer's credit history and current commitments to better determine their capability of repaying debt. This will also enhance Veda Group's product offering, making it a key growth area. As highlighted by the Fairfax press, Veda Group doesn't believe that the $2.70 per share offer price takes this potential growth into account.

Indeed, comprehensive credit reporting generated significant growth in the UK and Hong Kong when it was introduced, suggesting Equifax may need to increase its bid for the Australian provider.

As it stands, Veda's shares are trading at a slight discount to the $2.70 offer price, suggesting investors aren't altogether confident that Equifax or another bidder will offer something more. Investors who own the shares may want to hold on in case a superior bid does emerge, but investors looking to put some new money to work in the market might be better looking elsewhere, for now.

Motley Fool contributor Ryan Newman has no position in any stocks mentioned. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. You can follow Ryan on Twitter @ASXvalueinvest. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »